Actionable news
0
All posts from Actionable news
Actionable news in RNN: REXAHN PHARMACEUTICALS Inc,

Rexahn Pharma Q3 results

Rexahn Pharmaceuticals (RNN +3.3%) Q3 results: Revenues: $0; R&D Expense: $3.1M (+72.2%); SG&A: $1.6M (+23.1%); Operating Loss: ($4.7M) (-51.6%); Net Loss: ($4M) (-110.5%); Loss Per Share: ($0.02)...


More